Early Phase 1 Irritable Bowel Syndrome Trial, Recruiting (NCT06612411)

Early Phase 1 Irritable Bowel Syndrome Trial, Recruiting NCT06612411 Sponsor: Jinling Hospital, China Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT06612411 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Irritable Bowel Syndrome (IBS), confirmed using a standard set of diagnostic guidelines called the Rome IV criteria
You are between 16 and 80 years old
You do not have other gut or bowel conditions such as inflammatory bowel disease, infectious diarrhea, or bowel tumors

Who may not be able to join:

You have been taking probiotics, stomach acid-reducing medications (called PPIs), antibiotics, or any medicines that affect uric acid levels within at least one month before the study
You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06612411

Sponsor: Jinling Hospital, China

Phase: Early Phase 1

Status: Recruiting

Condition: Irritable Bowel Syndrome

More information: https://clinicaltrials.gov/study/NCT06612411

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Irritable Bowel Syndrome (IBS), confirmed using a standard set of diagnostic guidelines called the Rome IV criteria
You are between 16 and 80 years old
You do not have other gut or bowel conditions such as inflammatory bowel disease, infectious diarrhea, or bowel tumors

Who may not be able to join:

You have been taking probiotics, stomach acid-reducing medications (called PPIs), antibiotics, or any medicines that affect uric acid levels within at least one month before the study
You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

Jinling Hospital, China

Registry

ClinicalTrials.gov

Start date

1 June 2024

Est. completion

31 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The score of IBS-SSS before and after intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov